Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

LA Jolla Pharma (LJPC)

LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

LA Jolla Pharma 201 Jones Road Suite 400 Waltham MA 02451 USA

www.lajollapharmaceutical.com P: 617-715-3600

Description:

LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.

Key Statistics

Overview:

Market Capitalization, $K 155,108
Enterprise Value, $K 112,348
Shares Outstanding, K 24,937
Annual Sales, $ 75,720 K
Annual Net Income, $ 19,660 K
Last Quarter Sales, $ 10,430 K
Last Quarter Net Income, $ 0 K
60-Month Beta 2.39
% of Insider Shareholders 36.30%
% of Institutional Shareholders 97.06%
Float, K 15,885
% Float 63.70%
Short Volume Ratio 0.43

Growth:

1-Year Return 69.95%
3-Year Return -39.96%
5-Year Return -79.07%
5-Year Revenue Growth 12,112.90%
5-Year Earnings Growth 112.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.08 on 08/15/22
Latest Earnings Date 08/18/22
Earnings Per Share ttm 0.15
EPS Growth vs. Prev Qtr -99.95%
EPS Growth vs. Prev Year -27.27%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 01/14/14

LJPC Ratios

Ratio
Price/Earnings ttm 51.83
Price/Earnings forward 155.50
Price/Earnings to Growth N/A
Return-on-Equity % -5.46%
Return-on-Assets % 4.00%
Profit Margin % 25.96%
Debt/Equity 0.00
Price/Sales 2.05
Price/Cash Flow 7.95
Price/Book N/A
Book Value/Share -2.76
Interest Coverage 2.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar